Clinical Trials Arena on MSN
Immuneering progresses MAPK inhibitor in lung and pancreatic cancer
The biotech will now take atebimetinib to mid- and late-stage trials in NSCLC and pancreatic cancer, respectively.
James Chen, CMT is an expert trader, investment adviser, and global market strategist. Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician ...
Faculty of Biotechnology, Jagiellonian University, ul. Gronostajowa 7, 30-387 Krakow, Poland, Max Planck Institute for Biochemistry, Am Klopferspitz 18A, D-82152 Martinsried, Germany, International ...
A study from the University of Maryland, Baltimore County (UMBC), published in Nature Communications, reveals how ...
New psychoactive substances, originally developed as potential analgesics but abandoned due to adverse side effects, may ...
After defeating the Pattonville Pirates (7-6) 45-0 on Saturday, the Nixa Eagles (13-0) are headed back to the Class 6 state championship game for the second consecutive year. The mix of rain, sleet, ...
4. Fighting for Humanity in the Age of the Machine. 25 November 2025 58 minutes Available for over a year Rutger Bregman's 2025 Reith Lectures, called "Moral Revolution", explore the moral decay and ...
As we celebrate our 125th year, we do so with a renewed sense of purpose. Guided by our strategic vision and driven by our shared values, we are confident that we will rise to meet this moment and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results